301 related articles for article (PubMed ID: 24947195)
1. Original hypothesis: Extracorporeal shockwaves as a homeostatic autoimmune restorative treatment (HART) for Type 1 diabetes mellitus.
Craig K; d'Agostino C; Poratt D; Walker M
Med Hypotheses; 2014 Sep; 83(3):250-3. PubMed ID: 24947195
[TBL] [Abstract][Full Text] [Related]
2. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
3. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
[TBL] [Abstract][Full Text] [Related]
4. Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement.
Wan XX; Zhang DY; Khan MA; Zheng SY; Hu XM; Zhang Q; Yang RH; Xiong K
Front Endocrinol (Lausanne); 2022; 13():859638. PubMed ID: 35370989
[TBL] [Abstract][Full Text] [Related]
5. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
[TBL] [Abstract][Full Text] [Related]
6. Potential role of TRAIL in the management of autoimmune diabetes mellitus.
Bernardi S; Norcio A; Toffoli B; Zauli G; Secchiero P
Curr Pharm Des; 2012; 18(35):5759-65. PubMed ID: 22726118
[TBL] [Abstract][Full Text] [Related]
7. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.
Vanikar AV; Trivedi HL; Thakkar UG
Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for diabetes: potential role of stem cells.
Stanekzai J; Isenovic ER; Mousa SA
Diabetes Res Clin Pract; 2012 Dec; 98(3):361-8. PubMed ID: 23020931
[TBL] [Abstract][Full Text] [Related]
9. FTZ promotes islet β-cell regeneration in T1DM mice via the regulation of nuclear proliferation factors.
Zhong Q; Yin J; Wang K; Chen X; Wang H; Hu X; Wang W; Wang L; Bei W; Guo J
J Ethnopharmacol; 2023 Oct; 315():116564. PubMed ID: 37244407
[TBL] [Abstract][Full Text] [Related]
10. Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet regeneration.
Cobo-Vuilleumier N; Gauthier BR
Metabolism; 2020 Mar; 104():154137. PubMed ID: 31904355
[TBL] [Abstract][Full Text] [Related]
11. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes.
Ventriglia G; Nigi L; Sebastiani G; Dotta F
Biomed Res Int; 2015; 2015():749734. PubMed ID: 26339637
[TBL] [Abstract][Full Text] [Related]
13. Stem cell-based therapy for the treatment of Type 1 diabetes mellitus.
Krishna KA; Rao GV; Rao KS
Regen Med; 2007 Mar; 2(2):171-7. PubMed ID: 17465749
[TBL] [Abstract][Full Text] [Related]
14. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
[TBL] [Abstract][Full Text] [Related]
15. Robo4-mediated pancreatic endothelial integrity decreases inflammation and islet destruction in autoimmune diabetes.
Troullinaki M; Chen LS; Witt A; Pyrina I; Phieler J; Kourtzelis I; Chmelar J; Sprott D; Gercken B; Koutsilieris M; Chavakis T; Chatzigeorgiou A
FASEB J; 2020 Feb; 34(2):3336-3346. PubMed ID: 31916652
[TBL] [Abstract][Full Text] [Related]
16. A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.
Casu A; Trucco M; Pietropaolo M
Pediatr Clin North Am; 2005 Dec; 52(6):1779-804. PubMed ID: 16301093
[TBL] [Abstract][Full Text] [Related]
17. [Reprogramming pancreatic cells to β cells].
Vieira A; Druelle N; Courtney M; Avolio F; Ben-Othman N; Pfeifer A; Gjernes E; Faurite B; Collombat P
Med Sci (Paris); 2013; 29(8-9):749-55. PubMed ID: 24005630
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic role of endothelial progenitor cells in Type 1 diabetes mellitus.
Grapensparr L; Olerud J; Vasylovska S; Carlsson PO
Regen Med; 2011 Sep; 6(5):599-605. PubMed ID: 21916595
[TBL] [Abstract][Full Text] [Related]
20. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
